This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Cancer Research Technology Limited. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2017
Title: James Donald Firth: Innovator in Therapeutic Compounds
Introduction
James Donald Firth is a notable inventor based in London, GB. He has made significant contributions to the field of therapeutic compounds, particularly in the development of triazolo compounds. With a total of 4 patents to his name, Firth's work has the potential to impact the treatment of various diseases.
Latest Patents
Firth's latest patents focus on [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds. These compounds are designed to inhibit AXL receptor tyrosine kinase function, which plays a crucial role in several proliferative conditions, including cancer. The inventions also encompass pharmaceutical compositions that utilize these compounds for therapeutic purposes, both in vitro and in vivo.
Career Highlights
James Donald Firth is associated with Cancer Research Technology Limited, where he continues to advance his research in therapeutic innovations. His work is pivotal in the ongoing fight against diseases mediated by AXL receptor tyrosine kinase.
Collaborations
Firth has collaborated with notable colleagues such as Grégoire Alexandre Pavé and Lorna Stewart. Their combined expertise contributes to the innovative research being conducted at Cancer Research Technology Limited.
Conclusion
James Donald Firth's contributions to the field of therapeutic compounds highlight his role as an influential inventor. His work in developing triazolo compounds is paving the way for new treatment options in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile